Press Releases

3/5/2007 Javelin to Present at the Oppenheimer ''Positioning Investors for the Next Wave in Pain Management'' Conference on March 6, 2007	6.0 KB
2/26/2007 Javelin Pharmaceuticals Signs Commercial Supply Agreement with Precision Pharma Services	8.4 KB
2/21/2007 Javelin Pharmaceuticals Names Derek Gallacher as European Managing Director	8.3 KB
1/30/2007 Javelin Pharmaceuticals Announces Results of FDA Meeting for Nasal Ketamine	9.8 KB
12/13/2006 Javelin Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference	6.7 KB
12/11/2006 NGN Capital's Managing General Partner Georg Nebgen Joins Javelin Pharmaceuticals Board of Directors	8.6 KB
12/1/2006 Javelin Pharmaceuticals to Host 2006 Analyst and Institutional Investor Day	8.7 KB
11/15/2006 Javelin Pharmaceuticals Reports Third Quarter 2006 Results	12.6 KB
11/3/2006 Javelin Pharmaceuticals to Present at The 17th Annual CIBC World Markets Healthcare Conference	6.7 KB
11/2/2006 Javelin Pharmaceuticals to Present at The Rodman & Renshaw Techvest 8th Annual Healthcare Conference	6.3 KB
10/25/2006 New, Favorable US and EU Assessments of NSAID Safety Bode Well For Javelin's Dyloject(TM)	9.4 KB
10/25/2006 Frost & Sullivan Names Javelin Pharmaceuticals Entrepreneurial Company of the Year for Intranasal Therapeutics	10.2 KB
9/26/2006 Javelin Pharmaceuticals To Present Recent Clinical Results of Its Lead Product Dyloject(TM) at UBS Global Life Sciences Conference	6.4 KB
9/14/2006 Javelin's Phase 2B Study Successful: Final Analysis Demonstrates Low Doses of Dyloject(TM) Rapidly Relieve Postoperative Pain	10.0 KB
9/12/2006 CORRECTING and REPLACING Javelin Pharmaceuticals, Inc. To Present Final Analysis of Phase 2b Study Results of Dyloject(TM) at Prestigious European Pain Conference - September 14th 2006	8.9 KB
9/12/2006 Javelin Pharmaceuticals, Inc. To Present Final Analysis of Phase 2b Study Results of Dyloject(TM) at Prestigious European Pain Conference - September 14th 2006	8.3 KB
9/6/2006 Javelin Pharmaceuticals, Inc. To Present at Roth Capital Partners 2006 New York Conference on September 7th 2006	6.2 KB
8/14/2006 Javelin Pharmaceuticals Reports Second Quarter 2006 Results	11.2 KB
7/20/2006 American Stock Exchange Lists Common Stock of Javelin Pharmaceuticals, Inc.	5.3 KB
7/19/2006 Javelin Pharmaceuticals CEO Dr. Daniel Carr to Be Interviewed Live on MN1.com Radio	6.4 KB
Showing 101-120 of 156 releases Page: 1 2 3 4 5 6 7 8  See Previous 20 | See Next 20

CONTACT US   JOIN US   SITE MAP
© 2010 Javelin Pharmaceuticals,Inc. / Intrac,Inc. / IDDS,Inc. All rights reserved. All other trademarks are the properties of their respective owners. Reproduction in whole or in part in any form or medium without express written permission of Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. is prohibited.